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Abstract
New insecticides are urgently needed because resistance to current insecticides allows resurgence of disease-transmitting
mosquitoes while concerns for human toxicity from current compounds are growing. We previously reported the finding of
a free cysteine (Cys) residue at the entrance of the active site of acetylcholinesterase (AChE) in some insects but not in
mammals, birds, and fish. These insects have two AChE genes (AP and AO), and only AP-AChE carries the Cys residue. Most
of these insects are disease vectors such as the African malaria mosquito (Anopheles gambiae sensu stricto) or crop pests
such as aphids. Recently we reported a Cys-targeting small molecule that irreversibly inhibited all AChE activity extracted
from aphids while an identical exposure caused no effect on the human AChE. Full inhibition of AChE in aphids indicates
that AP-AChE contributes most of the enzymatic activity and suggests that the Cys residue might serve as a target for
developing better aphicides. It is therefore worth investigating whether the Cys-targeting strategy is applicable to
mosquitocides. Herein, we report that, under conditions that spare the human AChE, a methanethiosulfonate-containing
molecule at 6 mM irreversibly inhibited 95% of the AChE activity extracted from An. gambiae s. str. and .80% of the activity
from the yellow fever mosquito (Aedes aegypti L.) or the northern house mosquito (Culex pipiens L.) that is a vector of St.
Louis encephalitis. This type of inhibition is fast (,30 min) and due to conjugation of the inhibitor to the active-site Cys of
mosquito AP-AChE, according to our observed reactivation of the methanethiosulfonate-inhibited AChE by 2-
mercaptoethanol. We also note that our sulfhydryl agents partially and irreversibly inhibited the human AChE after
prolonged exposure (.4 hr). This slow inhibition is due to partial enzyme denaturation by the inhibitor and/or micelles of
the inhibitor, according to our studies using atomic force microscopy, circular dichroism spectroscopy, X-ray
crystallography, time-resolved fluorescence spectroscopy, and liquid chromatography triple quadrupole mass spectrometry.
These results support our view that the mosquito-specific Cys is a viable target for developing new mosquitocides to
control disease vectors and to alleviate resistance problems with reduced toxicity toward non-target species.
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Introduction
Mosquitoes are a principal insect vector of infectious diseases
that afflict both developing countries and industrialized nations.
For example, Anopheles gambiae sensu stricto transmits malaria in
Sub-Saharan Africa [1], Culex pipiens L. transmits St. Louis
encephalitis [2] and West Nile virus [3], and Aedes aegypti L.
transmits dengue, yellow fever, and chikungunya [4]. Recently,
mosquito populations have surged due to emergence of insect
populations with increased resistance to common insecticides.
Another important factor in pest resurgence is lax control
measures owing partly to growing concerns about insecticide
safety [5]. Such concern may be well founded, since many
insecticides phosphorylate or carbamylate indiscriminately a
ubiquitous catalytic serine residue at the active site of acetylcho-
linesterase (AChE, EC 3.1.1.7), a serine hydrolase vital for
regulating cholinergic neurotransmission in mammals, birds, fish,
and insects [6]. Thus, there is an urgent need for novel insecticides
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6851to control mosquito-borne diseases, especially malaria. According
to World Malaria Report 2008 (http://apps.who.int/malaria/
wmr2008/), half of the world’s population is at risk of malaria, and
an estimated 247 million cases led to nearly 881,000 deaths in
2006.
Unlike mammals, many disease-transmitting or crop-pest insects
have two AChE genes (AP and AO) [7–12]. Interestingly, a free
cysteine (Cys) residue, for example, Cys286 of An. gambiae s. str.
AP-AChE (AgAP-AChE), is present at the entrance to the active
site of insect AP-AChEs but not at that of AO-AChEs and AChEs
from mammals, birds, and fish [13–15]. In addition, mosquitoes
have an additional arginine residue (Arg339 of AgAP-AChE) at the
rim of the AP-AChE active site that appears to be genus-specific
[14]. Recently we reported that a methanethiosulfonate-contain-
ing molecule designed to target the active-site Cys residue
irreversibly inhibited all AChE activity extracted from aphids
while an identical exposure caused no effect on the human AChE
[16]. We also reported that the irreversible inhibition is primarily
caused by the formation of a disulfide bond between the inhibitor
and the Cys residue as evident from the reversal of inhibition by 2-
mercaptoethanol, a disulfide-bond-breaking agent [16]. These
results show that AP-AChE is responsible for most of the
acetylcholine-hydrolyzing activity in aphids, and they prove the
concept that the active-site Cys residue in aphid AP-AChE is a
viable target for developing insect-selective pesticides to control
crop damage caused by aphids.
In this context, it appears worth exploring new inhibitors that
target two mosquito-specific residues (Cys286 and Arg339 of
AgAP-AChE or their equivalents of other mosquito species) to
control mosquito-borne diseases. Such agents can alleviate the
resistance problem because they are novel and because the
targeted residues stabilize the active-site conformation [14] and
hence are relatively resistant to selective pressure. Equally
important, these chemicals should be less toxic to mammals than
current anticholinesterases that attack the ubiquitous catalytic
serine residue of all AChEs.
On the other hand, it has been reported that iodoacetamide-
containing AChE inhibitors do not bond covalently to AgAP-
AChE [17]. Since iodoacetamide is a commonly used sulfhydryl
agent, such a finding would suggest that the active-site Cys residue
in AgAP-AChE is not targetable, a conclusion advanced in a recent
reconsideration of this issue [18]. Further questions regarding Cys-
targeting inhibitors arise from our own observation that such
inhibitors can inhibit the human AChE (hAChE) in irreversible
fashion, although this enzyme has no Cys residue near its active
site [16]. Therefore, a re-investigation of the extent and
mechanisms of irreversible inhibition of AgAP- and mammalian
AChEs by sulfhydryl agents is required before pursuing mosqui-
tocides that target the two mosquito-specific residues.
In this article, we report data confirming that Cys286 of AgAP-
AChE or its equivalent in the Ae. aegypti or C. pipiens is targetable by
sulfhydryl agents and that AP-AChE contributes most of the
measurable AChE activity in An. gambiae s. str., Ae. aegypti, and C.
pipiens. Our studies also offer new insights into irreversible inhibition
mechanisms for AChEs from different species. The results support
our notion that the mosquito-specific Cys is a viable target for new
mosquitocides to control disease vectors and to alleviate resistance
problems with reduced toxicity toward non-target species.
Results
2.1. Irreversible Inhibition of Mosquito AChEs
To investigate whether the active-site Cys residue of mosquito
AP-AChE can be targeted by sulfhydryl agents and to determine
how much AP-AChE contributes to AChE activity in mosquito,
we tested the inhibition of total AChE activity in extracts from
three mosquito species using our recently reported assay protocol
and active-site-Cys-targeting inhibitors, AMTS7–AMTS20 [16]
and BPA11 (see Figure 1). At 6 mM, AMTS17–AMTS20 are
known to irreversibly inhibit aphid AChEs but not hAChE [16].
AMTSn have a trimethylammonium group on one end of an
alkylene chain to confer affinity through a cation-pi interaction
with Trp87 at the active site [19,20] and a methanethiosulfonate
group on the other end to form an adduct preferentially with a free
cysteine residue [21]. Based on the same design principle, BPA11
was made according to the scheme in Figure 1 to replace the
trimethylammonium and methanethiosulfonate groups of
AMTSn with 4-amino-pyridinium and bromide, respectively, for
the purpose of retaining affinity while reducing reactivity toward
Cys residues ‘‘in general’’ (i.e., to minimize interactions with non-
target SH-containing proteins).
An. gambiae s. str., Ae. aegypti,a n dC. pipiens were selected for this
study on the basis of diseaserelevance, local prevalence, and their AP-
AChE sequences that contain the mosquito-specific residues of Cys
and Arg at the rim of the active site [14,16]. Crude extracts rather
than purified or recombinant AP-AChEs were used to delineate the
relative role of AP-AChE in insect AChE activity. AChE inhibition
assays on limited samples were enabled by a method that measures
hydrolysis of
3H-acetylcholine [22] with a sensitivity that allowed 200
determinations with a 10:1 signal-to-blank ratio from a single
mosquito. Importantly, this radiometric assay precluded false
inhibition and other interference that could arise with the standard
Ellman method [23] owing to a reaction between the substrate,
thiocholine, and the Cys-targeting sulfhydryl reagents under study.
We exposed a mosquito extract to each AMTSn at 6 mM for
1 hour and then dialyzed overnight against a large excess of 0.09%
NaCl and 0.1 M sodium phosphate at pH of 7.4 to remove the free
inhibitor before assay of residual AChE activity using the
radiometric assay (see Section 4.3). Analysis of inhibition as a
function of compound length revealed a broad peak of AChE
inhibitory activity with a maximal inhibition near 100% in the
case of An. gambiae s. str. and .80% in the case of Ae. aegypti or C.
pipiens (Figure 2A). The AChEs from all three species were
Figure 1. Chemical structures of AMTS7–AMTS20 and BPA11
and a synthetic scheme for BPA11.
doi:10.1371/journal.pone.0006851.g001
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AMTS15), but for each species the long-chain inhibitors
(AMTS16–AMTS20) had the greatest selectivity of mosquito
AChE over hAChE. Consistently, 1 mM BPA11, an inherently less
reactive molecule of similar effective length, also caused selective
and irreversible inhibition of AgAChE after a 2.5-hour incubation,
although much lesser in extent (10%).
2.2. Slow, Partial, and Irreversible Inhibition of the Human
AChE
Although AMTS17–AMTS20 at 6 mM had shown no
irreversible inhibition of hAChE in our previously reported studies
[16], a full dose-response analysis detected irreversible inhibition
of hAChE at inhibitor concentrations of .10 mM (Figure 2B). The
inhibitory effect on hAChE by AMTS17–AMTS20 at 100 mMi s
similar to that previously reported at 6 mM for the less selective
compound, AMTS13 [16]. Likewise, when the BPA11 concen-
tration was increased from 1 to 100 mM, the irreversible inhibition
of hAChE rose from 0 to 30%. In the AMTSn series at a
concentration of 100 mM, the irreversible inhibition of hAChE
decreased with increasing chain length. Corresponding dose-
response studies of the longer-chain molecules with each mosquito
species showed that the concentration required to irreversibly
inhibit mosquito AChE by 50% was ,100-fold lower than
required to inhibit hAChE equivalently. The optimal combination
of potency and selectivity was achieved with AMTS17.
2.3. Characterization of Irreversible Inhibitions of AgAChE
and hAChE
The irreversible inhibition of hAChE by AMTSn at high
concentrations prompted further studies to confirm that the
irreversible inhibition of mosquito AChE by AMTSn is due to the
conjugation of the inhibitor to the active-site Cys residue and that
the irreversible mosquito AChE inhibition is mechanistically
different from the irreversible inhibition of hAChE. We charac-
terized the irreversible inhibition of AgAChE and hAChE by
AMTS13 or AMTS18 at 6 mM, as inhibitor concentrations of
.6 mM are less relevant to insecticide development. These
inhibitors were chosen because, as reported previously [16],
AMTS18 and AMTS13 showed 0% and 57% irreversible
inhibition of hAChE, respectively, at 6 mM with one-hour
exposure followed by prolonged dialysis.
In search of evidence for conjugation to the active-site Cys
residue, we found that 2-mercaptoethanol caused significant
reactivation of the AMTS13-inhibited AgAChE (data not shown)
and the AMTS18-inhibited AgAChE (Table 1), although it
concomitantly reduced the catalytic activity of the apo AgAChE.
The latter was presumably due to disulfide bond reduction in
AChE by 2-mercaptoethanol (see Section 3.1.1). In contrast, the
hAChE activity inhibited by AMTS18 was not restored by 2-
mercaptoethanol (Table 1), nor by pralidoxime [24], a commonly
used agent for regenerating a free catalytic serine residue of AChE
(data not shown). These results indicate that the irreversible
inhibition of mosquito AChE is mechanistically different from that
of hAChE.
In additional studies we observed that glutathione conjugated to
AMTS13 within seconds while by itself having no detectable effect
on AChE activity in extracts from mosquitoes, human red blood
cells (RBCs), or recombinant hAChE (rhAChE). The rapid
conjugation enabled us to determine the time course of the
irreversible AChE inhibition by adding excess glutathione to a
reaction solution to remove the free inhibitor abruptly and
completely (control experiments revealed no sign of reactivation
when fully inhibited enzyme was exposed to glutathione). Such
time-course studies showed that 6 mM AMTS13 caused rapid
irreversible inhibition of AgAChE, with a half-time less than 10
minutes and nearing completion within 30 minutes (Figure 3A). By
contrast, a four-hour incubation with the same inhibitor at 6 mM
was needed to achieve 30% irreversible inhibition of rhAChE
(Figure 3B). Thus, the irreversible inhibition of AgAChE by 6 mM
AMTS13 is fast and nearly complete, while that of similarly
treated rhAChE is slow and partial. The different time-courses
offer additional evidence that the mechanisms for irreversible
inhibition of the two enzymes are distinct.
2.4. Micelle Formation of AMTSn Detected by Atomic
Force Microscopy
One possible cause for the slow, partial, and irreversible
inhibition of hAChE is partial enzyme denaturation induced by
micelles of AMTSn that might form under the incubation
Figure 2. Effects of inhibitor length and concentration on AChE inhibition by AMTSn. (A) Irreversible AChE inhibition determined in
extracts from An. gambiae s. str., Ae. Aegypti, C. pipiens, and human RBCs exposed to 6 mM AMTSn followed by overnight dialysis. (B) Dose response
analysis of irreversible inhibition by AMTS18 in three mosquito species and hAChE.
doi:10.1371/journal.pone.0006851.g002
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with atomic force microscopy (AFM) [25,26] and found that
AMTS13, AMTS17, and AMTS18 do not form micelles at 6 mM
in distilled water. However, in samples with 100 mM sodium
phosphate at pH 7.4, used in AMTSn incubation and for dialysis,
AFM detected abundant micelles for AMTS13 and AMTS17 at
6 mM but no micelles for 6 mM AMTS18 (Figure 4). Interestingly,
AMTS17 at 6 mM did not form micelles in 10 mM sodium
phosphate at pH 7.4 (Figure 4). In contrast, AMTS13 still formed
detectable micelles at the same low ionic strength. A point relevant
tothe reactivationstudydescribed inSection2.3wasthatmicellesof
AMTS13 did not disappear in the presence of 100 mM 2-
mercaptoethanol, a condition that reversed the inhibitory effect of
AMTS13 on AgAChE activity or on aphid AChE activity as
reported previously [16]. These results further support that the fast,
nearly full, and irreversible inhibition of AgAChE is caused by the
conjugation of AMTS13 to the active-site Cys residue, and suggest
that the slow, partial, and irreversible inhibition of hAChE is due to
partial enzyme denaturation induced by micelles of AMTS13.
2.5. Circular Dichroism Spectroscopy Study on AMTS13-
Treated rhAChE
To test the inhibition mechanism for hAChE suggested by the
AFM study, we acquired far-UV circular dichroism (CD) spectra
for rhAChE at different conditions over the range of 220–250 nm
in which a random coil or a nonpeptidic molecule results in zero
absorption whereas an a helix and a b strand give rise to strong
negative signals [27]. As shown in Figure 5, the apo rhAChE has
the most negative absorption (211.5 cm
21M
21) at 220 nm,
consistent with reported CD spectra for AChEs from different
species [28–30]. When the apo rhAChE was partially denatured by
elevating temperature to 90uC, the absorption at 220 nm rose to
27.8 cm
21M
21 (Figure 5), indicating a reduction of ordered
secondary-structural elements in the AChE structure. When 5 mM
rhAChE was treated with a 100-fold molar excess of AMTS13 for
48 hours, the absorption at 220 nm changed from
211.5 cm
21M
21 to 28.5 cm
21M
21 (Figure 5). The far-UV CD
spectra clearly indicate that AMTS13 reduces secondary struc-
tures or causes partial denaturation of rhAChE.
2.6. Crystal Structure of Mouse AChE in Complex with
AMTS13
It is possible that the irreversible inhibition of hAChE could
reflect not only partial denaturation, but also a reaction with the
catalytic serine residue, as previously speculated [16]. To further
investigate the latter possibility, we determined the X-ray crystal
structure of a recombinant mouse AChE (rmAChE) in complex
with AMTS13 (AMTS13NrmAChE). Consistent with the AFM
Figure 3. Time courses of irreversible inhibition for mosquito and human AChEs by AMTS13. Extracts of An. gambiae s. str. larva and
rhAChE were exposed, respectively, to 6 mM AMTS13 at room temperature for defined intervals of time terminated by addition of glutathione (to a
final concentration of 500 mM). Shown is AChE activity in treated samples assayed radiometrically.
doi:10.1371/journal.pone.0006851.g003
Table 1. Partial Reactivation of the AMTS18-inhibited AgAChE by 2-Mercaptoethanol (2ME), Which Reverses the AMTS18 Inhibition
and Concomitantly Denatures AgAChE.
Pretreatment Treatment Incubation Time (hr)
Raw AgAChE
activity (cpm)
% AgAChE activity reduced
by 2ME and/or AMTS18
% AgAChE activity
recovered by 2ME
None None 2 8400 0
’’ None 6 5130 0
’’ 2ME 2 5900 30
’’ 2ME 6 4500 12
AMTS18 None 2 25 100 0
’’ None 6 11 100 0
’’ 2ME 2 894 89 15
’’ 2ME 6 1400 73 31
The An. gambiae s. str. extracts were exposed to AMTS18 (6 mM) for 1 hour and/or to 2ME (100 mM) for different periods of time. After the exposure(s), samples were
dialyzed overnight and the AChE activity was measured. Activities are mean values of triplicate determinations expressed as percentages of the AgAChE activity.
doi:10.1371/journal.pone.0006851.t001
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diffracting AMTS13-soaked crystals were difficult to obtain when
using a protocol that has routinely yielded good quality crystals of
rmAChE in complex with other reversible or irreversible inhibitors.
The AMTS13NrmAChE crystals generally displayed high mosai-
city and low resolution. After shortening the AMTS13 exposure to
two minutes, however, the mosaicity decreased, permitting
acquisition of a dataset with a resolution of 2.6 A ˚ (Table 2).
The AMTS13NrmAChE structure resolved by this approach is
generally similar to that of the apo rmAChE [31], with an alpha
carbon root mean square deviation of 0.27 A ˚ for monomer A. In
the AMTS13NrmAChE crystal structure, the well-defined electron
densities at the bottom of the active-site gorge reveal no sign of a
covalent bond between AMTS13 and Ser203. Instead, AMTS13
spans the active-site gorge, with its linker adopting an extended
conformation to interact with side chains of Tyr72, Tyr124,
Trp286, Phe297, Phe338, and Tyr341, and with its ammonium
group engaging in a cation-pi interaction with Trp86 (Figure 6A).
The –SO2CH3 group was undefined as the electron density of the
inhibitor is slightly disordered at the opening of the gorge
(Figure 6). While this structure does not support the reaction with
the catalytic serine residue, it does support the concept underlying
our design strategy, namely that the ammonium group of
AMTS13 is near Trp86 and its methanethiosulfonate group is
located in the acyl-loop region where the insect-specific Cys resides
in mosquito AChEs.
Figure 4. Atomic force microscopic images of AMTS18, AMTS17, and AMTS13 at different conditions.
doi:10.1371/journal.pone.0006851.g004
Figure 5. Circular dichroism spectra of AMTS13 and rhAChE at
different conditions.
doi:10.1371/journal.pone.0006851.g005
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3.1. Distinct Irreversible Inhibition Mechanisms for
AgAChE and hAChE
Before discussing results in relation to our primary goal, which
was to determine whether or not the active-site Cys residue of
AgAP-AChE can be targeted selectively by sulfhydryl agents, it is
necessary to consider mechanisms for the two distinct irreversible
inhibitions of AgAChE and hAChE by 6 mM AMTS13 described
in Sections 2.1–2.3.
3.1.1. Irreversible Inhibition through Disulfide Bond
Formation
We deem it likely that the fast, nearly complete, and irreversible
inhibition of AgAChE by 6 mM AMTS13 is initiated by a
reversible interaction between the ammonium group of AMTS13
and Trp84 of AgAP-AChE, placing the methanethiosulfonate
group at the rim of the gorge. This puts the reactive group close to
the free Cys residue and facilitates a rapid conjugation of the
inhibitor to AgAP-AChE. Our AMTS13NrmAChE crystal structure
supports the initial reversible inhibition. The subsequent conjuga-
tion step is evident from our observation that 2-mercaptoethanol
caused significant reactivation of the AMTS13-inhibited AgAChE.
One may note that the 31% of AMTS18-inhibited AgAChE
activity restored by 2-mercaptoethanol was less than half of the
previously reported 76% of AMTS13-inhibited aphid AChE
activity [16]. This quantitative difference is consistent with the
conjugation mechanism and can be explained by the sequence
difference between aphid and mosquito AChEs (Table 3) as
discussed below.
In the Torpedo californica AChE crystal structure, Cys254-Cys265
is more exposed to solvent than Cys67-Cys94 and Cys402-Cys521
[19,20]. It is known that Cys254-Cys265 can be ruptured readily
by X-ray irradiation while the other disulfide bonds were either
not affected or elongated by ,0.7 A ˚ under the same experimental
condition [32,33]. We found that Cys254-Cys265 or its equivalent
in other AChEs is akin to Cys6-Cys120 of a-lactalbumin in terms
of the location of the disulfide bond and the surrounding cationic
residue (Figure 7), while Cys6-Cys120 is reportedly 140-times
more reactive to reducing agents than normal disulfide bonds due
to conformational strain at this locus [34]. We also found that the
strain energy of the most solvent-exposed disulfide bond in
mammalian AChE is about 0.6 kcal/mol higher than those of the
others in mammalian AChE (Table 4), according to the density
functional theory calculations using the coordinates of the
AMTS13NrmAChE crystal structure and the procedure detailed
in Section 4.10. It is conceivable that the most solvent-exposed
disulfide bond in mammalian AChE is reactive to 2-mercaptoe-
chanol and that variation in the sequence that governs the strain
energy of the disulfide bond can change AChE’s sensitivity to the
reducing agent. Therefore, one should not expect 100%
reactivation of the AMTS13-o rAMTS18-inhibited insect AChE,
nor, given the sequence variations shown in Table 3, should one
expect the percentage of reactivation for AgAChE to equal that for
aphid AChE.
3.1.2. Irreversible Inhibition through Partial Enzyme
Denaturation
Previously we speculated that the slow, partial, and irreversible
inhibition of hAChE by 6 mM AMTS13 could be caused by a
reaction of AMTS13 with the catalytic serine residue (Ser203),
which is activated for nucleophilic reactions [16]. However, the
AMTS13NrmAChE crystal structure at a resolution 2.6 A ˚ reveals
no sign of a covalent bond between AMTS13 and Ser203,
whereas a covalent bond between Ser203 and an organopho-
sphonate or organophosphate is routinely observed under the
same crystallographic conditions [35–38]. Moreover, the crystal
structure shows that the methanethiosulfonate group is distant
from Ser203. These findings are in agreement with our
preliminary study using liquid chromatography triple quadrupole
mass spectrometry. This study identified FGESAGAASV
(895.4 m/z), but FGES
S(CH2)13N+(Me)3AGAASV could not be
identified, even in a sample of rhAChE that had been inhibited to a
level of 70% by 72-hour treatment with AMTS13 before pepsin
digestion under acidic conditions. Therefore, the Ser203-involving
mechanism now appears highly unlikely.
A more plausible inactivation mechanism in view of our studies
using AFM and far-UV CD spectroscopy is partial denaturation of
the enzyme induced by AMTS13 and/or micelles of AMTS13.
Two pieces of evidence for this mechanism are (1) the far-UV CD
spectra that show a reduction of secondary structures of rhAChE
treated with AMTS13 for 45 hours and (2) the AFM results
indicating AMTS13’s high propensity for micelle formation. The
partial denaturation mechanism is further supported by the
following considerations.
First, it has been reported that alkyltrimethylammonium halides
with 12–16 methylenes, in particular dodecyl-trimethylammonium
halides (DDTMAHs), are effective surfactants that can denature a-
lactalbumin or b-lactoglobulin [39,40]. Although methanethiosul-
fonate is slightly hydrophilic, the overall structure of AMTS13 is
analogous to DDTMAHs. While 6 mM AMTS17 does not form
micelles under low ionic strength condition and 6 mM AMTS18
Table 2. Data Collection and Refinement Statistics.
Data collection AMTS13NrmAChE
PDB entry code 2WLS
Wavelength (A ˚) 0.948
Space group P212121
Unit cell dimensions (A ˚)7 8 . 5 6110.36227.6
Resolution range (A ˚)2 9 . 0 22.6 (2.7422.6)
Total no. of reflections 450881 (65154)
Unique reflections 61580 (8866)
Completeness 99.8 (100.0)
Multiplicity 7.3 (7.3)
Rmerge
1 0.083 (0.525)
Mean(I)/sd(I) 17.2 (4.4)
Refinement
R-factor
2/Rfree
3 0.19/0.23
RMS bond lengths (A ˚) 0.008
RMS bond angle (u) 1.130
Ramachandran plot
4 %/no. of residues
Favored regions 95.8/1015
Allowed regions 3.8/40
Outlier region 0.5/5
1Rmerge=(g|I – ,I.|)/gI, where I is the observed intensity and ,I. is the
average intensity obtained after multiple observations of symmetry related
reflections.
2R-factor=(g||Fo|–|Fc||)/g|Fo|, where Fo and Fc are observed and calculated
structure factors, respectively.
3Rfree uses 2% randomly chosen reflections defined in Brunger [47].
4The Ramachandran plots were determined using the program Rampage [52].
doi:10.1371/journal.pone.0006851.t002
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6 mM AMTS13 forms micelles under both low and high ionic
strength conditions. The relative propensities of AMTS13,
AMTS17, and AMTS18 for micelle formation agree with the
reported range of the alkyl chain length for effective surfactants
comprised of alkylene cations. In this sense AMTS13 resembles
DDTMAHs. Therefore, it is conceivable that AMTS13 can fully
or partially denature AChE just as DDTMAHs denature b-
lactoglobulin [39].
Second, AMTS13 has most of the structural features of
DDTMAHs but, since it possesses a slightly hydrophilic metha-
nethiosulfonate group, it cannot be quite so effective in denaturing
proteins. The partial denaturing effect on AChEs that we ascribe
to the AMTS13 structure agrees very well with our observation
that, after 22-hour exposure to AMTS13, inhibition of hAChE
was inversely related to the concentration of acetylcholine (ACh)
substrate in the enzyme assay, dropping from 85% at 1 mM ACh
to 75% at 1 mM, 65% at 10 mM, and 57% at 50 mM. As
apparent from Figure 8, substrate at high concentrations inhibited
AChE in control enzyme preparations. This well-known effect
[41] is presumably due to the binding of ACh at the peripheral
‘‘anionic’’ site. Strikingly, AMTS13 exposure prevented the
substrate inhibition. This outcome implies that AMTS13 did
not totally inactivate a subset of hAChE molecules but partially
denatured most (or all) of them, depressing but not eliminating
basic catalytic function. In addition, the loss of substrate inhibition
suggests that AMTS13 disturbed the peripheral ‘‘anionic’’ site.
Last, the posited partial denaturation also agrees with our time-
resolved fluorescence decay study on native or heat-denatured
rhAChE with or without treatment with AMTS13 for 0, 24, and
48 hours. It is well-known that intrinsic Trp fluorescence in
proteins is sensitive to local structural change induced by
denaturation, ligand binding, or other means [42]. Since rhAChE
has 13 Trp residues located in different local environments, we
conducted studies on the intrinsic fluorescence lifetime (ti) and its
amplitude (ai). In our preliminary results (Table 5), the most
noticeable change of fluorescence properties was that heating,
treating with AMTS13, or extending the incubation time (with or
without AMTS13) all led to an increase in a1. The largest increase
(from 2.6% to 7.9%) occurred in the sample that was heated and
treated with AMTS13. The second most noticeable change was
that t1, t2, and t3 of the heated enzyme were noticeably longer
than those of the unheated ones. Finally, all changes of t1 and a1
caused by AMTS13 were, although lesser in extent, in the same
Figure 6. X-ray crystal structure of AMTS13NrmAChE (cyan)
and the superimposed apo rmAChE crystal structure (grey). The
2|Fo|–| F c|( 1s) and |Fo|–| F c|( 3s) electron density maps are shown in
blue and green, respectively.
doi:10.1371/journal.pone.0006851.g006
Table 3. The Sequence That Governs the Conformation of
the Most Solvent-Exposed Disulfide Bond in
Acetylcholinesterases of Different Species.
Species Sequence
Homo sapiens CPPGGTGGNDTELVAC
Mus musculus CPPGGAGGNDTELIAC
Schizaphis graminum CPDDRNTIHKTVEC
Anopheles gambiae sensu stricto CPHEPSKLSDAVEC
Torpedo californica CNLNSDEELIHC
doi:10.1371/journal.pone.0006851.t003
Mosquito AChE Inhibitors
PLoS ONE | www.plosone.org 7 August 2009 | Volume 4 | Issue 8 | e6851direction as those caused by heating. In other words, the results are
consistent with the mechanism that rhAChE underwent partial
denaturation during treatment with AMTS13. Further studies
could define how AMTS13 denatures AChE. In our view,
however, the present evidence, from multiple complementary
approaches, is sufficient to establish a partial denaturation
mechanism for the slow, incomplete, and irreversible inhibition
of mammalian AChEs by AMTS13.
Because AMTS17 also forms micelles at 6 mM in buffers of
high ionic strength, and its structure is at the borderline of
surfactant classification, it is understandable why AMTS17 does
not cause significant irreversible inhibition of hAChE until its
concentration reaches 100 mM. At the same time, it is worth
emphasizing that partial denaturation does not apply to the fast,
nearly complete, and irreversible inhibition of insect AChE by
lower concentrations of AMTS17 and its longer chain analogs.
That is clear for three reasons. First, in 10 mM sodium phosphate,
6 mM AMTS17 did not form micelles but irreversibly inhibited
nearly 100% of AgAChE (data not shown). Second, in 100 mM
sodium phosphate, 6 mM AMTS17 did form micelles but did not
inhibit hAChE. Last, the irreversible inhibition of the AgAChE was
reversed by 100 mM 2-mercaptoethanol in 100 mM sodium
phosphate, but these conditions did not prevent AMTS17 from
forming micelles.
3.1.3. Summary of the Two Distinct Irreversible Inhibition
Mechanisms
We found the irreversible inhibition of AgAChE by 6 mM
AMTS13 to be fast and nearly complete, and that of hAChE to be
slow and partial. We explain the first inhibition as the conjugation
of AMTS13 to the active-site Cys residue of AgAP-AChE, and the
second as partial enzyme denaturation induced by AMTS13, free
or in micelles. These mechanisms are attributed to two key
features of the AMTS13 structure: (1) a methanethiosulfonate
group reactive toward free cysteine residues and (2) an
alkyltrimethylammonium analogous to surfactant DDTMAHs.
3.2. Novel Mosquitocides for Controlling Mosquito-Borne
Diseases
In the context of the irreversible inhibition mechanisms for
insect and mammalian AChEs discussed above, the present work
demonstrates that the mosquito-specific Cys residue at the
entrance of the AP-AChE active site can be targeted by a strong
sulfhydryl agent such as AMTS17 or a weak alkylating agent such
as BPA11. The present work also shows that the Cys residue can
be targeted selectively by 1 mM BPA11 or 6 mM AMTS17. Because
6 mM AMTS17 has a low propensity for micelle formation and is
thus unlikely to denature AO-AChE and mammalian AChEs, and
because .80% AChE activity in mosquito is rapidly and
irreversibly inhibited by AMTS17, we deduce that AP-AChE
contributes most of the measurable AChE activity in the three
studied mosquito species. It is true that mosquitoes possess both
AP and AO AChEs and that irreversible AChE inhibition assays
are more complicated than reversible inhibition assays. Neverthe-
less, all results presented in this article fit within a unified frame
and support our view that the insect-specific Cys residue at the
entrance of the AP-AChE active site in mosquito is a viable target.
We recognize that honeybees and silkworms also have AP-
AChE with an analogous active-site Cys residue [14]. This fact
raises a legitimate concern that Cys-targeting mosquitocides could
harm these beneficial insects. Fortunately, there is an arginine
residue residing on the rim of the AP-AChE active site conserved
in several mosquito species but not found in other insects [14]. If
Figure 7. Structurally similar disulfide bonds in rmAChE (green)
and a-lactalbumin (yellow).
doi:10.1371/journal.pone.0006851.g007
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specific residues (e.g., Cys286 and Arg339 of AgAP-AChE), it might
be possible to reduce insecticide toxicity to mammals, fish, birds,
and non-target insects that do not have the corresponding Cys and
Arg residues. That would offer the prospect of controlling
mosquito-borne diseases and alleviating resistance problems with
reduced toxicity toward non-target species.
AChE is a well-studied enzyme and there is extensive literature
on developing effective AChE inhibitors several of which are used
currently as insecticides or even as clinical drugs for treating the
Alzheimer’s disease. It is therefore practical to develop the insect-
specific insecticide concept illustrated in this article into an
effective insecticide that targets the two mosquito-specific residues.
Because insecticides are a well-established approach to controlling
mosquito-borne diseases with a clear infrastructure and concept-
of-use in the field, the insect-specific insecticides should enable
rapid implementation of a cost-effective solution to controlling
mosquito-borne diseases globally.
3.3. Conclusion
Under conditions that spare hAChE, low-concentration
AMTS17 is able to quickly, selectively, and irreversibly inhibit
most of total AChE activity extracted from mosquitoes that
transmit malaria, dengue, yellow fever, chikungunya, or St. Louis
encephalitis. A much smaller but still selective and irreversible
inhibition of mosquito AChE activity can also be achieved by a
weak alkylating agent, BPA11. These inhibitors can slowly,
partially, but also irreversibly inhibit human or mouse AChE at
higher inhibitor concentrations. The mechanism for the fast,
selective, nearly complete, and irreversible inhibition of mosquito
AChE by long-chain compounds is their conjugation to the active-
site Cys residue of mosquito AP-AChEs. The mechanism for the
slow, nonspecific, partial, and irreversible inhibition of mamma-
lian AChEs by short-chain and less selective agents is partial
enzyme denaturation induced by the agents or by their detergent-
like micelles. The present results imply that AP-AChE contributes
most of the acetylcholine hydrolyzing activity in mosquitoes. They
also demonstrate that the insect-specific free Cys residue at the
entrance of the AP-AChE active site in mosquito can be targeted
selectively by sulfhydryl agents with varied reactivity toward
thiolate. Inhibitors targeting the insect-specific Cys residue and the
mosquito-specific Arg residue hold promise in controlling
mosquito-borne diseases and alleviating resistance problems with
reduced toxicity toward non-target species.
Materials and Methods
4.1. Mosquitoes and Chemicals
An. gambiae s. str. (G3, MRA-112) colonies obtained from the
Malaria Research & Reference Reagent Resource Center
(Manassas, VA) were maintained in the Department of Entomol-
ogy at Kansas State University, and fourth-instar larvae were used
in the study. Adult Ae. aegypti and C. pipiens were from the
Department of Entomology of the University of Minnesota. Group
AB human RBCs, bovine serum albumin (BSA), and rhAChE were
obtained from Sigma-Aldrich (St Louis, MO, USA) as were 1,11-
dibromoundecane, 4-(Boc-amino)pyridine, 2-mercaptoethanol,
glutathione, acetylcholine iodide, pepsin, buffer constituents, and
miscellaneous laboratory reagents. (6)-Dithiothreitol was pur-
chased from Sigma-Aldrich (Buchs, Germany). Tritiated acetyl-
choline (99 mCi/mM) was purchased from New England Nuclear
(Waltham, MA, USA). Cesium carbonate was obtained from AK
Scientific (Mountain View, CA). Hexanes (Hex), ethyl acetate
(EtOAc), and trifluoroacetic acid (TFA) were purchased from
Fisher Scientific (Pittsburgh, PA) and used without purification.
AMTS7–AMTS20 were synthesized as previously described [16].
4.2. Synthesis of 11-bromo-N-(pyridin-4(1H)-
ylidene)undecan-1-aminium trifluoroacetate (BPA11)
The
1H and
13C NMR spectra were recorded on a Varian
Mercury 400 spectrometer. Chemical shifts are reported in ppm
using either tetramethylsilane or the solvent peak as an internal
standard. Data are reported as follows: chemical shift, multiplicity
(s=singlet, d=doublet, t=triplet, q=quartet, m=multiplet),
coupling constant, and integration. Medium pressure liquid
chromatography (MPLC) was performed with Biotage SP-1
Table 4. Conformational Strain Energies of the Three Disulfide Bonds in the AMTS13NrmAChE Crystal Structure.
Disulfide Bond Torsion* (u of arc) Energy (kcal/mol)
X1 X2 X3 X29 X19 Conformational Relative Strain
Cys257- Cys272 262613 277611 26265 2102661 6 7 610 21121502 11
Cys409- Cys529 26964 24660 28664 23761 27762 21121508 5
Cys69- Cys96 27664 245628 6 621 3 0 676 3 64 2112513 0
*X1=N-CA-CB-SG, X2=CA-CB-SG-SG’, X3=CB-SG-SG’-CB’, X29=SG-SG’-CB-CA, and X19=SG’-CB’-CA’-N’.
doi:10.1371/journal.pone.0006851.t004
Figure 8. Substrate dependence of hAChE inhibition in extracts
of human RBCs pretreated with AMTS13. Samples were exposed
to 6 mM AMTS13 f o r2 2 h o u r sa n dd i a l y z e do v e r n i g h tb e f o r e
radiometric assay. Shown are residual hAChE activities as a function
of substrate concentration in AMTS13-treated samples and paired
controls.
doi:10.1371/journal.pone.0006851.g008
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Cesium carbonate (195 mg, 0.6 mmol) and 1,11-dibromounde-
cane (0.47 mL, 2.0 mmol) were added to a stirred solution of 4-
(Boc-amino)pyridine (97 mg, 0.5 mmol) in anhydrous dimethyl-
formamide (2 mL). After stirring for 7 hours at room temperature,
the reaction mixture was diluted with water (2 mL) and extracted
with EtOAc (2650 mL). The combined organic extracts were
washed with brine (365 mL), dried over MgSO4, and concen-
trated in vacuo. The residue was purified by MPLC (Hex:EtOAc/
3:2) to give tert-butyl 11-bromoundecyl(pyridin-4-yl)carbamate as
oil (153 mg, 72%).
1H NMR (400 MHz, CDCl3) d 8.46 (m, 2H),
7.19 (m, 2H), 3.65 (t, J=7.6 Hz, 2H), 3.37 (t, J=6.8 Hz, 2H),
1.81 (m, 2H), 1.55 (m, 2H), 1.46 (s, 9H), 1.38 (m, 2H), and 1.23
(m, 12H).
13C NMR (100 MHz, CDCl3) d 153.66, 150.44, 150.12,
119.14, 81.67, 48.98, 34.28, 33.00, 29.69, 29.60, 29.58, 29.40,
28.93, 28.69, 28.46, 28.35, and 26.91. This intermediate (153 mg,
0.36 mmol) was dissolved in 5 mL anhydrous dichloromethane
followed by dropwise addition of 2 mL TFA and then stirred at
room temperature for 3 hours. Removal of TFA and solvent in
vacuo gave BPA11 as a white solid (167 mg) in quantitative yield.
BPA11 used for in vitro testing was further purified by high
performance liquid chromatography using a Phenomenex Gemini
column (5 mm, C18, 250621.20 mm), eluting with 50% of
solution A (1000 mL of H2O and 1 mL of TFA) and 50% of
solution B (100 mL of H2O, 900 mL of CH3CN, and 1 mL of
TFA), and a flow rate of 10 mL/minute with a retention time of
24.60 minutes for BPA11 (see Figures S1, S2, S3, S4 for proton
NMR spectra and chromatograms of BPA11 before and after the
HPLC purification).
1H NMR (400 MHz, DMSO-d6) d 13.01 (s,
1H), 8.51 (s, 1H), 8.18 (d, J=6.4 Hz, 1H), 8.02 (d, J=6.8 Hz,
1H), 6.82 (dd, J=6.8, 14.4 Hz, 2H), 3.50 (t, J=6.4 Hz, 2H), 3.22
(dd, J=6.8, 12.8 Hz, 2H), 1.79–1.72 (m, 2H), 1.54–1.49 (m, 2H),
and 1.32–1.23 (m, 14H);
13C NMR (100 MHz, DMSO-d6) d
158.52, 141.44, 139.11, 110.43, 105.25, 42.77, 35.93, 32.90,
29.60, 29.54, 29.34, 28.77, 28.57, 28.18, and 26.96.
4.3. Measurement of AChE Inhibition
Mosquitoes were stored at 220uC, as were preparations of washed
human RBC membranes prepared as described elsewhere [43]. For
experiments involving exposure to test compounds and subsequent
dialysis, one to five insects were homogenized twice for 10 seconds
each in ground glass homogenizers containing 1 mL of an ice-cold
solution of 0.09% NaCl, 0.1 M sodium phosphate at pH 7.4, 0.1%
BSA, and Triton X-100 (0.5% v/v). RBC samples were prepared
similarly but by sonication for 5 to 10 sec. In both cases the resulting
fine suspensions were diluted 30-fold in the homogenization buffer
before treatments and assays, and they were thoroughly re-suspended
byvortexmixingaseachaliquotwastransferredtothereactiontubes.
This procedure yielded duplicate agreements within62% for
mosquito AChE activity and within61% for RBC AChE activity.
Experiments calling for sample exposure to inhibitors or
reactivating reagents involved steps to separate the small molecules
from the enzyme before determinations of AChE activity. Some
data reported in this article were obtained after dialysis for 16–
24 hours against two changes of 0.09% NaCl and 0.1 M sodium
phosphate at pH 7.4 in more than 100-fold excess. This standard
biochemical procedure was validated by control experiments
demonstrating its ability to remove all traces of inhibitory activity
as tested with sentinel samples of AChE. Time-course data were
obtained by rapid inactivation of a test inhibitor using reduced
glutathione (final concentration 500 mM).
The AChE assays were based on an established radiometric
technique in which product (
3H-labeled acetic acid) liberated
enzymatically from substrate (
3H-labeled acetylcholine, 50 nCi in
a final reaction volume of 100 mL at pH 7.4) is partitioned into
4 mL of toluene-isoamyl alcohol (5:1, v/v) with scintillation fluor
[22,44]. As a rule, the assays were performed with substrate in a
concentration of 0.1 mM. This condition allowed maximum
sensitivity (active samples more than 10 times the buffer-only
blanks) with small samples (5 mg wet weight equivalent) and high
temporal resolution (assay times as short as 5 min). Also, because
of the low substrate concentrations a reversible 50% inhibition was
expected to occur at concentrations near the true Ki. When
necessary, substrate concentration was adjusted by diluting stock
material (99 mCi/mM) with unlabelled acetylcholine chloride.
Assay duration, at room temperature, was rigorously controlled to
ensure that signal was robust (.5 times blank value) and remained
linear with respect to time and amount of sample present (typical
conditions, 5 minutes for concentrated samples or up to 4 hours
for highly dilute or low activity samples).
4.4. AChE Reactivation by 2-Mercaptoethanol
Reactivation by 2-mercaptoethanol was examined with AChE
samples that were exposed for 1 hour to an inhibitor at 6 mM final
concentration, followed by dialysis overnight against two changes
of .100 volumes of 0.09% NaCl and 0.1 M sodium phosphate at
pH 7.4. A few experiments (specifically indicated) used longer
treatment times. Treated samples were exposed to 2-mercapto-
ethanol at a final concentration of 100 mM for 2 or 6 hr, followed
by a second overnight dialysis against the phosphate buffer.
Table 5. Time-Resolved Fluorescence Intensity Decays of rhAChE at Different Conditions.
sample t1 (ns) a1 (%) t2 (ns) a2 (%) t3 (ns) a3 (%) x
2
rhAChE, 0 hr 0.28060.110 2.660.3 2.09160.065 43.661.1 5.01560.054 53.961.4 0.8560.03
rhAChE, 24 hr 0.13560.025 2.860.3 1.98560.042 42.261.0 4.83960.036 54.161.2 0.7960.06
rhAChE, 48 hr 0.42260.033 3.860.1 2.25160.015 49.360.7 5.23560.037 47.060.8 0.9060.01
rhAChE+ AMTS13, 0 hr 0.20260.108 3.960.4 1.89560.082 45.361.6 5.01560.091 50.862.1 0.8260.03
rhAChE+ AMTS13, 24 hr 0.18960.092 3.360.1 1.84760.067 47.061.5 4.61060.090 49.761.6 0.7860.01
rhAChE+ AMTS13,4 8h r
1 0.39060.037 4.461.5 1.99960.093 49.662.1 4.76960.129 46.963.7 0.8560.01
rhAChE, 90uC
2 0.494 5.8 2.529 44.0 6.346 50.2 1.02
rhAChE+AMTS13,9 0 uC
2 0.480 7.9 2.439 45.3 6.172 46.8 0.97
1Mean value6S.D. of two independent measurements at 20uC.
2Single measurement of a 48 hours sample incubated at 90uC for 20 minutes prior to measurement.
doi:10.1371/journal.pone.0006851.t005
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A Nanoscope IIIa SPM atomic force microscope (Digital
Instruments, Inc., Santa Barbara, CA, USA) was used to detect
micelle formation. About 0.5 mg of AMTS13, AMTS17,o r
AMTS18 was dissolved in 1 mL of DMSO, and an aliquot
(,5.9 mL) of the stock solution was diluted to 6 mM with 1 mL of
deionized water or 100 mM sodium phosphate (pH 7.4) with or
without 100 mM 2-mercaptoethanol. To a freshly cleaved mica,
25 mLo fAMTS13, AMTS17,o rAMTS18 at 6 mM was added,
and the compound was allowed to bind onto the mica surface for
three minutes. The unbound sample was removed by washing
twice with deionized water (80 mL each), and the compound-
bound mica was dried under a stream of argon. AFM images were
collected using a tapping mode (http://www.veeco.com) with a
high aspect ratio tip, Veeco Nanoprobe TM tips (Nanoscience
Instruments Inc., Pheonix, AZ, USA). Each experiment was
repeated three times. AFM images of the three repeated
experiments for each compound showed similar sizes of micelles,
and one representative image from the three experiments was
shown in Figure 4.
4.6. Circular Dichroism Spectroscopy
rhAChE at 5 mM was treated with or without 500 mM
AMTS13 for 48 hours at 20uC in a buffer of 0.1 M sodium
phosphate at pH 7.4. The circular dichroism spectra were
obtained on a Jasco J810 spectrapolarimeter at 20uC using a
path-length of 1 mm. Initial measurement in the 200–250-nm
range revealed a rapid increase of the dynode voltage around
220 nm. However, a twofold dilution with water allowed
measurement in the 220–250 nm range. Two measurements
(each comprising eight scans) were performed for rhAChE treated
with or without AMTS13 at 20uC, whereas one measurement was
made for the apo rhAChE heated to 90uC (70uC/hour).
4.7. X-Ray Crystallography
4.7.1. Generation of rmAChE crystals. Cloning, expre-
ssion, purification, and crystal screening of the apo rmAChE were
performed as previously described [35]. An AMTS13-containing
soaking solution was prepared by dissolving approximately 3 mg
of AMTS13 into 100 mL OX-buffer made of 28% (v/v)
polyethylene glycol 750 monomethylether and 100 mM HEPES
at pH 7.0. This was so that the concentration of AMTS13 was
much higher than the KD of AMTS13 for rmAChE. Crystals of
rmAChE were first allowed to equilibrate slowly in OX-buffer at
20uC. The AMTS13-bound rmAChE complex was then generated
by adding 3–5 mL of the AMTS13-containing soaking solution to
the crystals. After incubation for ,2 minutes the soaking was
terminated by flash freezing the crystals in liquid nitrogen.
4.7.2. Collection, processing, and refinement of diffrac-
tion data. The X-ray diffraction data were collected at the
MAXlab synchrotron centre (Lund, Sweden) using beam line I911-
3 on a MAR Research CCD detector. The images were collected
with an exposure time of 60 sec, an oscillation angle of 1.0u per
exposure, and the total oscillation range covered 180u. Intensity
data were indexed and integrated with XDS [45] and scaled using
Scala [45]. The AMTS13-bound rmAChE structure was
determined using rigid-body refinement on a modified structure
of apo rmAChE (Protein Data Bank entry code: 1J06 [31]) as a
starting model. To avoid model bias, Ser203, Trp286, and all small-
molecule ligands were removed from the starting model. Further
crystallographic refinement was carried out using the program
Refmac5 and phenix.refine [46]. The refinement included 98% of
the data while the remaining 2% was used to follow the progress of
the refinement with R-free [47]. The R-free dataset was obtained
from a previously determined structure (Protein Data Bank entry
code: 2GYU [35]). In the initial electron density map of the
AMTS13-bound rmAChE complex structure, a clearly visible
electron density feature spans the active-site gorge of rmAChE. Due
to the intermediate resolution of 2.6 A ˚ (Table 2), several rounds of
refinement were performed with consideration of two orientations
of AMTS13 relative to the rmAChE active site. One orientation is
with the AMTS13 ammonium group located close to Trp86 at the
bottom of the gorge, while the other is with the ammonium group
positioned close to Trp286 at the rim of the gorge. During the
progress of the refinement, it became apparent that a cation-pi
interaction between the ammonium group and the indole ring of
Trp86 is consistent with the crystallographic data. During the
refinement, a model was rebuilt manually after visualization of
2|Fo|–| F c|a n d| F o|–| F c| maps using the COOT program
[48]. Watermolecules wereadded usingCOOT, phenix.refine, and
by manual model building. The angles and bonds for the sulfhydryl
group were determined using the Gaussian98 program [49] and the
Hartree-Fock method with the 6-31G* basis set. The quality of the
final model was evaluated using PROCHECK, WHATCHECK,
and Rampage [50–52]. Figures were made using the PyMol
program [53].
4.8. Time-Resolved Fluorescence Spectroscopy
In all fluorescence measurements the excitation wavelength was
set to 295 nm to record only tryptophan emission and to exclude
interference of phenylalanine or tyrosine as an emitting species.
The rhAChE concentration was kept at 1.7 mM, a level that
corresponded to an O.D. of 0.04 at 295 nm, which was low
enough to avoid self-absorption processes. Background fluores-
cence from buffer solutions with 500 mM AMTS13 was always
checked. All measurements were performed at room temperature.
The time-resolved measurements with resolution down to sub-
nanosecond time regime were performed with time-correlated
single-photon counting (TCSPC) technique by using an IBH
spectrometer equipped with a data station hub, TBX-04 photon
detection module, light emitting diode Nanoled-17 (HORIBA
Jobin Yvon IBH) generating 295 nm UV-light pulses of 1 MHz
repetition rate, and a 5000 M single-grating emission monochro-
mator. The fluorescence emission was collected at 340 nm where
the monochromator spectral bandwidth was adjusted to 16 nm.
An instrumental response function was obtained using suspension
of silica particles (Ludox, Aldrich) in deionized water, which
typically gave a spectral width of about 600 ps at half maximum.
The fluorescence were measured over 4096 channels (13 ps per
channel), and fluorescence lifetimes (ti) and pre-exponential
factors, presented as amplitudes (ai), were calculated by fitting
experimental decays either with double or triple exponential
functions using the IBH DAS6 decay analysis software (such
functions are based upon least-squares fitting algorithms and
reconvolution with the experimental response function). The tri-
exponential fits typically gave x
2 in the range of 0.8–0.9, low
enough to be acceptable (those fits obtained with double
exponential functions typically displayed x
2 around 0.9–1.0).
Typically, the fluorescence decay was measured and the
mean6S.D. was calculated for three independent samples.
4.9. Liquid Chromatography Triple Quadrupole Mass
Spectrometry
Glutathione was reduced using (6)-dithiothreitol and subse-
quently reacted with AMTS13 to obtain AMTS13-glutathione.
With the aid of a triple quadrupole mass spectrometer (Waters/
Micromass Quattro, Milford, MA, USA), the conjugated gluta-
thione was verified and abundant fragments were determined
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has 272.3 m/z that corresponds to 13-(trimethylammonio)tride-
cane-1-thiolate. After treating rhAChE with AMTS13 for
72 hours, the enzymatic activity was reduced by 72%. This
partially inhibited enzyme was then split into two portions. One
was digested using pepsin under acidic conditions and the resulting
peptides were separated and analyzed using liquid chromatogra-
phy mass spectrometry (PepMap100, C18, 3 mm, 100 A ˚,
15060.075 mm, LC Packings, Netherlands; capLC pump,
Waters/Micromass, Milford, MA, USA). For the other, free
AMTS13 was removed (Spin-filter Microcon Ultracel YM-10,
Millipore, Bedford, MA, USA) prior to the pepsin digestion.
4.10. Density Functional Theory Calculations
The Gaussian98 program [49] was used to compute the strain
energies of the three disulfide bonds in the AMTS13NrmAChE
crystal structure. The coordinates of two cross-linked cysteine
residues were taken from the AMTS13NrmAChE crystal structure
(Protein Data Bank entry code: 2WLS); the amino and carboxylate
groups were masked by –COMe and –NHMe, respectively; the
entire system was fully optimized in vacuum using the B3LYP
method with the 6-311+G(d,p) basis set; frequency calculations
were performed after the energy minimizations to confirm the
minimized structures were at their minima (viz, no imaginary
frequency was found in the frequency calculation).
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